Navigation Links
Takeda to Acquire Inviragen, Inc.
Date:5/7/2013

e in the world."
  • Grow Takeda's product pipeline with vaccine candidates that protect against HFMD and chikungunya. 
  • Expand Takeda's current technical capabilities, which include virus-like particle and cell culture technologies, with Inviragen's live-virus and inactivated virus vaccine capabilities.
  • Contribute to Takeda's overall research and development programs, long-term growth strategy and commitment to improve the health of people and communities everywhere.
  • Acquisition Summary

    1. Acquiring companies: Takeda America Holdings, Inc. and Takeda Pharmaceutical Company Limited
    2. Shareholders of Inviragen, Inc.: EDBI, Charter Life Sciences, Venture Investors, and Phillip Private Equity
    3. Payment: Cash
    4. Number of fully diluted common and preferred stock equivalent to common outstanding shares: 39,035,439
    5. Acquisition amount: US$35 million
      1. In addition to this acquisition amount, the deal consideration includes with future contingent consideration based on the progress of development projects and commercial milestones up to US$215 million.
    6. Planned date of completion: Pending the satisfaction of customary closing conditions, the deal is expected to close within 14 days.
    7. Legal advisor to Takeda: Morgan, Lewis & Bockius LLP
    8. Financial advisor to Inviragen: Torreya Partners LLC
    9. Legal advisor to Inviragen: Wilson Sonsini Goodrich & Rosati

    Profile of Inviragen Inc.:

    1. Corporate Name: Inviragen, Inc.
    2. Headquarters: Fort Collins, CO, U.S.A.
    3. Wholly owned subsidiary: Inviragen (Singapore) Pte.Ltd., Singapore
    4. Representative: Dr. Dan Stinchcomb , Co-founder and CEO
    5. Year of establishment: 2005
    6. '/>"/>

    SOURCE Takeda Pharmaceutical Company Limited
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Takeda Responds to Verdict in Diabetes Drug Case
    2. Takeda Launches New Subsidiary in Ecuador
    3. Takeda lanza nueva subsidiaria en Ecuador
    4. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
    5. Takeda presenta la richiesta di autorizzazione allimmissione in commercio nellUnione Europea per Vedolizumab nella colite ulcerosa moderata-grave e nella malattia di Crohn
    6. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
    7. Takeda and Resolve Therapeutics Enter Autoimmune Partnership
    8. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
    9. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
    10. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
    11. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/25/2014)... PORT OF SPAIN, Trinidad and Tobago , ... Drugs Division of the Trinidad & Tobago Ministry ... the market, an innovative therapy that significantly increases the ... indicated for patients infected with the genotype 1 ... under the trade brand INCIVO®. ...
    (Date:7/25/2014)... -- Solanbridge Group Inc (OTC: SLNX) is pleased to announce ... and the Letter of Intent issued on July 11, ... Agreement. Charles R. Shirley , Managing ... Mr. David Pecoraro and Buzznbrewz.com join SLNX,s ... sector and developed a tremendous network of contacts who ...
    (Date:7/25/2014)... July 25, 2014 Research and Markets ... Ophthalmic Diagnostic Devices Market 2014-2018" report to their ... About Ophthalmic Diagnostic Device An ... identify a defect or deficiency in the human visual ... disorders such as presbyopia, cataracts, glaucoma, retinal disorders, conjunctivitis, ...
    Breaking Medicine Technology:The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3Solanbridge Group Inc Announces Acquisition of Buzznbrewz.com 2Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2
    (Date:7/25/2014)... 25, 2014 In recent years, men have ... to reverse the symptoms associated with age-related testosterone decline. Amid ... large, a new case study from Renew Man ... testosterone therapy using bioidentical hormones. , The case study ... Seattle who found himself beginning to feel the effects of ...
    (Date:7/25/2014)... As reported by the Statesman Journal in the article ... police in Salem, MA as well as several other states ... epidemic that has taken many lives during the past couple ... in which police were able to make two arrests by ... to be the victim and claiming to want to buy ...
    (Date:7/25/2014)... July 25, 2014 (HealthDay News) -- Seniors are more ... people, a new study finds. "Almost any type ... from the age of 25 on," study co-author Randi ... a university news release. However, Martin said, this ... on processing in older adults compared with younger adults. ...
    (Date:7/25/2014)... Island (PRWEB) July 25, 2014 Reproductive ... to announce that Dr. Kerri Luzzo, Lead Physician at ... Award" for her professional accomplishments in fertility care and ... , At the 10th Annual PBN Awards ceremony held ... Island, 40 of the most highly regarded, emerging leaders ...
    (Date:7/25/2014)... News) -- The human brain can preserve oxygen to ... study finds. Although dehydration significantly reduces blood ... that the brain compensates by increasing the amount of ... has helped us understand a lot more about how ... conditions," study first author Steven Trangmar, a researcher at ...
    Breaking Medicine News(10 mins):Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 3Health News:Multiple States Crack Down on Heroin Epidemic 2Health News:Distractions Seem More Troublesome With Age 2Health News:Dr. Kerri Luzzo of the Reproductive Science Center of Providence Receives “40 Under Forty Award" for Outstanding Professional Accomplishments and Community Outreach 2Health News:Human Brain Has Coping Mechanism for Dehydration 2
    ... Scientists at the University of Liverpool have identified high levels ... may suggest why they live longer than other rodents and ... recently generated the first whole-genome sequencing data of the naked ... years and is resistant to cancer - to understand its ...
    ... , THURSDAY, Nov. 3 (HealthDay News) --,When an ... can suffer fatal injuries, a new report suggests. That,s ... associated with these natural disasters occur when bridges and roads ... is disrupted, according to a group of Boston researchers who ...
    ... News) -- Smokers are more likely to kick the habit ... processes emotions was damaged by the stroke, researchers say. ... smoking before they had a stroke were much more likely ... about quitting. These findings may lead to new ways ...
    ... , THURSDAY, Nov. 3 (HealthDay News) -- A new ... calls into question the widespread practice of classifying children ... and their IQ scores, researchers report. ... many school systems in the United States to determine ...
    ... PHILADELPHIA - A research group at the Perelman School ... John Lynch, MD, PhD, assistant professor of Medicine in ... Institute (NCI) grant to establish a Barrett,s esophagus translational ... Timothy Wang) and the Mayo Clinic (led by Dr. ...
    ... federal government is investing billions of dollars to encourage ... technology so that all Americans can benefit from the ... about potential harm are emerging as providers increasingly rely ... information technologies to deliver care. ,HEALTH IT ...
    Cached Medicine News:Health News:Scientists identify genes that may signal long life in naked mole-rats 2Health News:Earthquakes Put Millions of Lives, Major Cities at Risk 2Health News:Some Smokers More Likely to Quit After Stroke Than Others 2Health News:Study Finds No Link Between Dyslexia and IQ 2Health News:Penn collaborates on $8 million Barrett's esophagus research network 2Health News:Penn collaborates on $8 million Barrett's esophagus research network 3
    ... magnification. The true benefit of this system ... focal clarity is made possible to to ... aluminum bar and individual pupillary adjustments provides ... focal alignment, eliminating headache and eyestrain., ,Ideal ...
    The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
    The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
    The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
    Medicine Products: